Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
Would you offer adjuvant radiotherapy to a young patient with microinvasive lobular carcinoma (< 1 mm) in a background of LCIS?
If a patient is <50 years old, would this change your recommendation?
Answer from: Radiation Oncologist at Community Practice
I would favor RT as part of BCS but would also like to know the LCIS type (pleomorphic or not) to better quantify the risk of IBTR.
Sign in or Register to read more
18942
Related Questions
How would you manage a patient presenting with recurrent cT4 breast cancer?
Would you offer PMRT for a small focus of invasive disease in a background of extensive DCIS?
Are there any solutions that allow for expensive dressings (e.g. Mepitel) to be billed to insurance, rather than having to pass the cost on to patients?
Would you offer RNI for young patient with cT3N0 triple negative breast cancer that had progression of disease during neoadjuvant chemotherapy, followed by mastectomy and sentinel node biopsy?
How do we reconcile what appears to be a more aggressive surgical resection for DCIS than for invasive disease?
How would you approach a cT4 cN2 (22 cm in size) TNBC that shrank to 9 cm with KN-522 regimen but remains inoperable at the end of treatment?
Would you consider PBI plus covering the regional lymph nodes for a LN+ breast cancer in the remnant of the axillary tail?
Have you seen any increased dermatologic toxicity with whole breast or chest wall radiation if patients have received recent or concurrent pembrolizumab?
What is your preferred PMRT dose/fractionation for patients with implant reconstruction?
When do you consider the addition of concurrent pembrolizumab to breast irradiation?